This study will evaluate several parameters: nutritional, functional, physical, and laboratorial assessments, including tests used for diagnosis and follow-up (TLR-4 and CK-18), and evaluation of degree of liver fibrosis, intestinal permeability, microbiota composition, and cardiovascular risk. The gene discussed is KRT18; the disease is Hepatic fibrosis.